Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02193932 · ClinicalTrials.gov registry record · NA
Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients
A NA study, sponsored by Baptist Health South Florida.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02193932: Completed NA study, sponsored by Baptist Health South Florida.
NCT02193932 is a NA study that has completed, run by Baptist Health South Florida. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02193932, a NA study, has completed, sponsored by Baptist Health South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Potential (ERP) recordings while the subject is inside the MRI machine, without compromising the raw EEG data.
Interventions
- OTHER EEG Triggered fMRI using Micro Maglink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-02-01 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
What the finished NCT02193932 record still lists
NCT02193932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which EEG Triggered fMRI using Micro Maglink is the first listed.
NCT02193932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02193932 about?
NCT02193932 is a clinical study titled "Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients". A prospective exploratory study in patients with drug resistant epilepsy with a target comparison of long term outcome. NeuroScan software modules and a MagLink will be used to acquire EEG in combination with MRI/fMRI data. The MagLink system is used for obtaining integrated EEG and Event Related Po...
What is the current status of trial NCT02193932?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2013-02-01. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT02193932?
The interventions under investigation include: EEG Triggered fMRI using Micro Maglink (OTHER).
Who is sponsoring clinical trial NCT02193932?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02193932's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI